- Home
- WKSP vs IMNN Comparison
WKSP vs IMNN Comparison
Compare WKSP & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- IMNN
- Stock Information
- Founded
- WKSP 2003
- IMNN 1982
- Country
- WKSP United States
- IMNN United States
- Employees
- WKSP N/A
- IMNN N/A
- Industry
- WKSP Auto Parts:O.E.M.
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- WKSP Consumer Discretionary
- IMNN Health Care
- Exchange
- WKSP Nasdaq
- IMNN Nasdaq
- Market Cap
- WKSP 14.6M
- IMNN 12.1M
- IPO Year
- WKSP N/A
- IMNN 1985
- Fundamental
- Price
- WKSP $3.03
- IMNN $0.77
- Analyst Decision
- WKSP Strong Buy
- IMNN Buy
- Analyst Count
- WKSP 3
- IMNN 2
- Target Price
- WKSP $12.83
- IMNN $14.00
- AVG Volume (30 Days)
- WKSP 177.5K
- IMNN 5.4M
- Earning Date
- WKSP 08-12-2025
- IMNN 08-13-2025
- Dividend Yield
- WKSP N/A
- IMNN N/A
- EPS Growth
- WKSP N/A
- IMNN N/A
- EPS
- WKSP N/A
- IMNN N/A
- Revenue
- WKSP $10,211,747.00
- IMNN N/A
- Revenue This Year
- WKSP $159.92
- IMNN N/A
- Revenue Next Year
- WKSP $68.25
- IMNN N/A
- P/E Ratio
- WKSP N/A
- IMNN N/A
- Revenue Growth
- WKSP 407.96
- IMNN N/A
- 52 Week Low
- WKSP $2.44
- IMNN $0.37
- 52 Week High
- WKSP $12.00
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- WKSP 50.10
- IMNN 40.14
- Support Level
- WKSP $2.80
- IMNN $0.93
- Resistance Level
- WKSP $3.14
- IMNN $1.03
- Average True Range (ATR)
- WKSP 0.28
- IMNN 0.18
- MACD
- WKSP -0.01
- IMNN -0.10
- Stochastic Oscillator
- WKSP 30.00
- IMNN 1.39
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).